Supply chain issues and strong travel demand continued in 2024.
Related Posts
Merck says experimental RSV treatment protected infants in trial, paving way for potential approval
Merck is discussing the study data with regulators worldwide, with a goal of making the treatment available for infants as early as the 2025 to […]
The worst (and best) stocks during Trump’s tough first 100 days
These are the stocks that have done the best and worst under Trump 2.0.
Stock futures are little changed after positive start to the holiday trading week: Live updates
The major averages posted modest gains on Monday to begin the holiday-shortened trading week.